NewGenIvf Unloads Entire XRP Position
Nasdaq-listed IVF company NewGenIvf (NIVF) disclosed in an SEC filing that it purchased 146,432 XRP in 2025 but sold the entire position before year-end.
The sale resulted in a $10,849 realized gain for the company. This was revealed through its latest financial update with the Securities and Exchange Commission.
NewGenIvf's decision to sell its XRP holdings is notable as it indicates a shift in the company's investment strategy. The company still maintains a position in Solana tokens, which remained on the books as of December 31.